The MS drug Goliath jumped into development of SP1 modulators last year, but a review of the competitive landscape resulted in a shuttering of the program this quarter, casting doubt on Biogen's future in the blockbuster indication.
Researchers have discovered that a protein in wheat triggers the inflammation in chronic health conditions, such as multiple sclerosis, asthma, and rheumatoid arthritis, and also contributes toward the development of nonceliac gluten...
Actelion to investigate all-oral combination therapy for patients with
relapsing multiple sclerosis
Actelion Pharmaceuticals Ltd /
Actelion to investigate all-oral combination therapy for patients with relapsing